Institutional investors hold a majority ownership of AGN through the 91.91% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended September 2014, these large investors purchased a net $5.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STRATEGIC ADVISERS, INC. Bought 167.3 Thousand shares of Allergan
ATALANTA SOSNOFF MANAGEMENT LLC Bought 118.0 Thousand shares of Allergan
QUANTITATIVE SYSTEMATIC STRATEGI... Bought 13.5 Thousand shares of Allergan